CONTROL study results show improved tolerability of NERLYNX® (neratinib) with all the investigated diarrhoea prophylaxis strategies
CASTRES, France, Dec. 10, 2021 /PRNewswire/ — Today, the final findings of the CONTROL study1 were presented at the 2021 San
Read More